StockComparison Logo
vs

GSK vs NEM

Comparison between GSK Plc (GSK, Company) and Newmont Corp (NEM, Company).

GSK is from the Healthcare sector, while NEM is from the Basic Materials sector.

5-Year PerformanceNEM has outperformed GSK, delivering a return of +12.1% compared to +4.9%

GSK vs NEM - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
GSK
$105B
NEM
$103B
Max Drawdown
Winner
GSK
64.03%
NEM
78.44%
Sharpe Ratio
Winner
GSK
1.37
NEM
1.16
5Y Beta
Winner
GSK
0.23
NEM
0.81
Industry
GSK
Drug Manufacturers - General
NEM
Gold
P/E Ratio
GSK
12.10
Winner
NEM
11.59
Forward P/E
GSK
21.69
Winner
NEM
9.46
PEG Ratio
GSK
0.10
Winner
NEM
0.03
Dividend Yield
Winner
GSK
3.59%
NEM
1.14%
5Y Dividends CAGR
Winner
GSK
1.34%
NEM
-2.62%
5Y EPS CAGR
GSK
4.65%
Winner
NEM
82.55%
Debt to Equity
GSK
106.74%
Winner
NEM
14.54%
Free Cash Flow Yield
GSK
8.03%
Winner
NEM
11.70%
P/S Ratio
Winner
GSK
3.22
NEM
3.88
P/B Ratio
GSK
4.37
Winner
NEM
2.91

GSK vs NEM - Historical Returns

Returns include dividend reinvestment.

1M
Winner
GSK
+0.08%
NEM
-9.15%
3M
Winner
GSK
-8.79%
NEM
-15.17%
6M
Winner
GSK
+7.35%
NEM
-21.86%
1Y
GSK
+45.38%
Winner
NEM
+56.17%
5Y(CAGR)
GSK
+4.87%
Winner
NEM
+12.10%
10Y(CAGR)
GSK
+4.02%
Winner
NEM
+11.30%
Max(CAGR)
GSK
+3.05%
Winner
NEM
+7.48%

GSK vs NEM - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

YearGSKNEM
2026+3.98%-8.20%
2025+50.62%+164.61%
2024-6.27%-6.78%
2023+9.25%-13.16%
2022-32.73%-19.45%
2021+23.62%+1.88%
2020-17.52%+41.03%
2019+30.36%+31.21%
2018+9.29%-7.71%
2017-3.80%+9.11%
2016+1.52%+85.47%
2015+0.48%-6.51%
2014-14.73%-20.37%
2013+26.97%-49.02%
2012-0.75%-23.06%
2011+22.51%-0.13%
2010-3.72%+27.88%
2009+20.27%+18.35%
2008-21.93%-21.54%
2007-2.77%+11.49%
2006+6.93%-20.35%
2005+9.96%+27.26%
2004+5.08%-8.08%
2003+25.04%+64.46%
2002-22.83%+52.76%
2001-9.58%+7.18%
2000+5.67%-28.66%
1999-5.78%+18.91%

GSK vs NEM Drawdown Comparison

The maximum drawdown for GSK was -50.11%, occurring on Sep 27, 2022. Recovery took 935 trading sessions.

The maximum drawdown for NEM was -76.55%, occurring on Sep 23, 2015. Recovery took 2127 trading sessions.

The current GSK drawdown is -15.65%. The current NEM drawdown is -29.58%.

RankGSKNEM
#1-50.11%
Apr 13, 2022 - Jan 6, 2026
-76.55%
Nov 7, 2011 - Apr 23, 2020
#2-49.64%
Apr 20, 2007 - Apr 18, 2012
-64.40%
Feb 1, 2006 - Jun 17, 2010
#3-45.23%
Apr 25, 2000 - Nov 11, 2005
-62.43%
Apr 18, 2022 - Sep 10, 2025
#4-32.56%
Jan 17, 2020 - Dec 10, 2021
-53.02%
May 4, 2000 - Mar 27, 2002
#5-27.97%
Mar 4, 2014 - Sep 3, 2019
-32.09%
Jan 28, 2026 - Jul 20, 2026
#6-26.98%
Nov 5, 1999 - Apr 11, 2000
-30.53%
May 28, 2002 - Jun 5, 2003
#7-18.61%
Feb 18, 2026 - Jun 2, 2026
-29.09%
Dec 2, 2003 - Dec 7, 2005
#8-14.45%
Jan 18, 2022 - Apr 7, 2022
-27.15%
May 18, 2021 - Mar 4, 2022
#9-10.52%
May 16, 2006 - Feb 13, 2007
-22.19%
Nov 24, 1999 - Feb 22, 2000
#10-10.48%
Oct 4, 2012 - Mar 22, 2013
-22.00%
Sep 22, 2010 - Sep 2, 2011
#11-8.45%
May 28, 2013 - Nov 1, 2013
-21.92%
Aug 5, 2020 - May 14, 2021
#12-8.43%
Apr 11, 2000 - Apr 25, 2000
-19.99%
Oct 16, 2025 - Dec 11, 2025
#13-8.16%
Nov 11, 2005 - Mar 8, 2006
-18.99%
May 15, 2020 - Jul 27, 2020
#14-7.54%
Feb 14, 2007 - Apr 16, 2007
-14.85%
Feb 22, 2000 - May 2, 2000
#15-7.37%
Jan 21, 2014 - Feb 13, 2014
-12.33%
Sep 20, 2011 - Nov 7, 2011

Correlation

Correlation between GSK and NEM is 0.63 which considered as a moderate positive correlation - the stocks show some tendency to move together.

0.63
-101

Dividend Comparison (1999 - 2026)

GSK vs NEM dividend yield comparison.

YearGSKNEM
20261.74%0.56%
20253.42%1.00%
20244.60%2.69%
20233.75%3.87%
20225.47%4.66%
20214.99%3.55%
20205.59%1.74%
20194.35%3.31%
20185.65%1.62%
20175.83%0.67%
20166.86%0.37%
20155.93%0.56%
20146.20%1.19%
20134.51%5.32%
20125.70%3.01%
20114.83%1.67%
20105.10%0.81%
20094.39%0.85%
20085.74%0.98%
20074.09%0.82%
20063.29%0.89%
20053.03%0.75%
20043.38%0.68%
20032.77%0.35%
20023.10%0.41%
20011.54%0.63%
20004.57%0.70%
19990.00%0.12%

Select Stocks to Compare